A study published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, estimates that the prevalence of acute hepatitis C virus (HCV) infection is nearly one percent among newly incarcerated inmates with a history of recent drug use. Findings suggest that systematic screening of intravenous (IV) drug users who are new to the prison system could identify more than 7,000 cases of HCV across the U.S. annuallyeven among asymptomatic inmates.
According to the National Institute of Allergy and Infectious Diseases Healththe funding organization for this current studychronic HCV affects 180 million people worldwide, with more than 4 million cases in the U.S. Studies have shown that most IV drug users acquire HCV with in the first year of risky injection habits and in the U.S. this population accounts for 46% of symptomatic acute infections. Due to past injection drug use, incarcerated inmates have HCV infection rates ranging from 25 percent to 41 percentroughly 20 times higher than the general population.
While the Centers for Disease Control and Prevention (CDC) recommend more vigilant surveillance of at risk populations, many healthcare programs in correctional facilities do not routinely screen for HCV, says Dr. Arthur Kim with the Division of Infectious Diseases at Massachusetts General Hospital and Harvard University Center for AIDS Research in Boston. Our study investigated whether the implementation of a low-cost, systematic screening process for high-risk behavior could uncover more asymptomatic acute HCV cases among newly incarcerated individuals who recently used injection drugs.
Between October 2006 and March 2008 the team assessed the health of 6,342 inmates with 55 percent of those screened for HCV. Of the 3470 inmates who were screened 24 percent were African-America, 50 percent Caucasian, and 22 percent percent Hispanic. Results show that 21 percent of the 171 high-risk inmates had acute HCV. Inmates who were diagnosed with HCV had a mean age of 29 years and 63 percent were female. This investigation found 91 percent of those with acute HCV were Caucasian, while no African-Americans were diagnosed with this disease.
Further analysis found that about one out of every hundred inmates screened were diagnosed with acute HCV infection. Kim adds, Based on estimates that 700,000 individuals enter the prison system each year, about 7,000 new cases of acute HCV infection would be identified if screening strategies were systematically adopted. Further validation of our screening approach in healthcare settings such as detoxification programs or emergency rooms is warranted. Adoption of such screening programs in high-risk populations would provide an opportunity for greater diagnosis and prevention of HCV.
Reference: A Simple Strategy to Identify Acute HCV Infection Among Newly Incarcerated Injection Drug Users. Arthur Y. Kim, Ellen H. Nagami, Christopher E. Birch, Melinda J. Bowen, Georg M. Lauer and Barbara H. McGovern. Hepatology; (DOI: 10.1002/hep.26113); March, 2013.
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.